Osborne's boost to the biotech industry

IBT's David Pinniger explains how the UK Budget has enhanced the investment story behind biotechnology.

Last Wednesday the UK Chancellor George Osborne announced his Budget which highlighted the government’s commitment to the UK biotechnology and medical science industry. The Government will invest an additional £100m in science capital development over the next two years, a portion of which will provide facilities for new medical research in key centres of excellence around the UK. Also included in the Budget were various tax and intellectual property allowances to encourage entrepreneurship and innovation – rightly regarded as key to the UK’s future competitiveness in an increasingly ...